CLINICAL INVESTIGATION OF CISPLATINE/PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Watanabe, K. [1 ]
Okuma, Y. [1 ]
Nakahara, Y. [1 ]
Yomota, M. [1 ]
Takagi, Y. [1 ]
Hosomi, Y. [1 ]
Okamura, T. [1 ]
机构：
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt460.21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
    Minami, Seigo
    Kijima, Takashi
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 13 - 25
  • [2] PHARMACOGENETIC STUDY IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NSCLC) TREATED WITH PEMETREXED
    Yasue, T.
    Hirashima, T.
    Kobayashi, M.
    Okamoto, N.
    Suzuki, H.
    Hosono, K.
    Morishita, N.
    Matsuura, Y.
    Tamiya, M.
    Shiroyama, T.
    Morita, S.
    Matsumoto, T.
    Morishita, H.
    Kawahara, K.
    Kawase, I.
    ANNALS OF ONCOLOGY, 2012, 23 : 136 - 136
  • [3] Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer
    Xu, Bei
    Liu, Peng
    Yin, Yongmei
    Liu, Ping
    Shu, Yongqian
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 763 - 769
  • [4] Pemetrexed for non-squamous non-small-cell lung cancer: experience in Northern Ireland
    Mulligan, C.
    Campbell, L.
    McAleese, J.
    Scullin, P.
    LUNG CANCER, 2011, 71 : S6 - S6
  • [5] Clinical Features of Non-Squamous Non-Small-Cell Lung Cancer Patients Treated with Long-Term Pemetrexed
    Hirai, Kenichiro
    Yokouchi, Hiroshi
    Azuma, Keisuke
    Minemura, Hiroyuki
    Sekine, Satoko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S420 - S420
  • [6] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Yaru Tian
    Hairong Tian
    Xiaoyang Zhai
    Hui Zhu
    Jinming Yu
    Frontiers of Medicine, 2022, 16 : 610 - 617
  • [7] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian, Yaru
    Tian, Hairong
    Zhai, Xiaoyang
    Zhu, Hui
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2022, 16 (04) : 610 - 617
  • [8] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian Yaru
    Tian Hairong
    Zhai Xiaoyang
    Zhu Hui
    Yu Jinming
    Frontiers of Medicine, 2022, 16 (04) : 610 - 617
  • [9] Rechallenge with pemetrexed- based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer
    Zhuo, Ming-Lei
    Bai, Hua
    Wang, Zhi-Jie
    Duan, Ran-Chun
    An, Tong-Tong
    Wu, Mei-Na
    Zhao, Jun
    Wang, Yu-Yan
    Wang, Shu-Hang
    Wang, Jie
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 953 - 959
  • [10] PREDICTIVE FACTORS FOR LONG-TERM RESPONSE TO PEMETREXED TREATMENT IN ADVANCED NON-SQUAMOUS, NON-SMALL-CELL LUNG CANCER PATIENTS
    Kwon, J.
    Kim, Y. J.
    Lee, K.
    Yoon, H. I.
    Kim, J. H.
    Lee, J.
    Lee, C.
    Lee, J. S.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S73 - S74
12345